LVW Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

LVW Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,182	Closed	-$238K	–	240
2021 Q3	$238K	Hold	3,182	–	–	0.04%	217
2021 Q2	$294K	Hold	3,182	–	–	0.05%	188
2021 Q1	$282K	Sell	3,182 -2,233	-41%	-$221K	0.05%	186
2020 Q4	$505K	Hold	5,415	–	–	0.1%	116
2020 Q3	$345K	Sell	5,415 -375	-6%	-$22K	0.08%	140
2020 Q2	$302K	Buy	+5,790	New	+$248K	0.07%	145

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LVW Advisors's ARKG Position: Q4 2021 in Review

LVW Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 3,182 shares — an estimated $238K sold.

LVW Advisors first reported a position in ARKG in Q2 2020 and held it in 6 quarters. The position peaked at $505K in Q4 2020. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

LVW Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
LVW Advisors sold 3,182 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $238K.
LVW Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 6 quarters.
LVW Advisors's ARK Genomic Revolution ETF position peaked at $505K in Q4 2020.
460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on LVW Advisors's 13F filing for Q4 2021, filed 26 Jan 2022.